Literature DB >> 22078276

Antimicrobial susceptibility patterns and sensitivity to tulathromycin in goat respiratory bacterial isolates.

Kristin A Clothier1, Joann M Kinyon, Ronald W Griffith.   

Abstract

Bacterial pneumonia is a common and often life-threatening respiratory problem in both meat and dairy goats. Options for approved antibiotic therapy in goats to combat these bacterial infections are severely limited and frequently drugs must be used in an extra-label manner. Tulathromycin, a triamilide macrolide antimicrobial drug shown to be effective against swine and cattle respiratory bacterial agents, has been identified as a potentially useful drug in caprines. The present study was conducted to determine the susceptibility of recognized bacterial respiratory pathogens to commonly prescribed antimicrobials, with a particular emphasis on the efficacy of tulathromycin against these agents. Minimum inhibitory concentration (MIC) testing using microbroth dilution was performed on a collection of 45 Mannheimia haemolytica, 11 Pasteurella multocida, and 11 Bibersteinia trehalosi isolates from the lungs of goats with clinical pneumonia. To further characterize efficacy of tulathromycin against these pathogens, minimum bactericidal concentration (MBC) testing and kinetic killing assays were conducted. Most isolates were susceptible to the antimicrobials tested; however, increased resistance as demonstrated by higher MIC values was seen in all species to penicillin, in P. multocida to sulfadimethoxine, and in B. trehalosi to the tetracyclines. All isolates were susceptible to tulathromycin, which demonstrated a high killing efficiency in both bactericidal assays. Results of this study indicate that most goat pneumonic bacterial pathogens remain susceptible to commonly prescribed antibiotics, although some evidence of resistance was seen to certain drugs; and that tulathromycin is highly effective against goat respiratory pathogens which could make it a valuable medication in this species. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22078276     DOI: 10.1016/j.vetmic.2011.10.025

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  5 in total

1.  Evaluation of a Pasteurella multocida Respiratory Disease Induction Model for Goats (Capra aegagrus hircus).

Authors:  Joe S Smith; Jonathan P Mochel; Yeon-Jung Seo; Amanda P Ahrens; Ronald W Griffith
Journal:  Comp Med       Date:  2020-09-09       Impact factor: 0.982

2.  Diversity of bacterial species in the nasal cavity of sheep in the highlands of Ethiopia and first report of Histophilus somni in the country.

Authors:  Biruk Tesfaye; Tesfaye Sisay Tessema; Genene Tefera
Journal:  Trop Anim Health Prod       Date:  2013-01-19       Impact factor: 1.559

3.  Comparing clinical effects of marbofloxacin and gamithromycin in goat kids with pneumonia.

Authors:  Yigit Kacar; Hasan Batmaz; Ozge E Yilmaz; Zafer Mecitoglu
Journal:  J S Afr Vet Assoc       Date:  2018-06-20       Impact factor: 1.474

4.  Assessment of animal diseases caused by bacteria resistant to antimicrobials: sheep and goats.

Authors:  Søren Saxmose Nielsen; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; Jose Luis Gonzales Rojas; Christian Gortazar Schmidt; Mette Herskin; Virginie Michel; Miguel Angel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Helen Clare Roberts; Hans Spoolder; Karl Stahl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Jeroen Dewulf; Luca Guardabassi; Friederike Hilbert; Rodolphe Mader; Francesca Baldinelli; Julio Alvarez
Journal:  EFSA J       Date:  2021-12-07

5.  Complete Closed Genome Sequences of Three Bibersteinia trehalosi Nasopharyngeal Isolates from Cattle with Shipping Fever.

Authors:  Gregory P Harhay; D Scott McVey; Sergey Koren; Adam M Phillippy; Jim Bono; Dayna M Harhay; Michael L Clawson; Michael P Heaton; Carol G Chitko-McKown; Jonas Korlach; Timothy P L Smith
Journal:  Genome Announc       Date:  2014-02-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.